ArticleClinical journal of the American Society of Nephrology : CJASN2026

Risk Assessment in Cardiovascular-Kidney-Metabolic Syndrome: An Opportunity to Individualize Evidence-Based Therapy in CKD.

L Parker Gregg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.